June 21, 2026
In this symposium, the role of aldosterone dysregulation in the pathophysiology of cardiovascular, endocrine, and renal diseases will be explained.
CME 1.00 Credits In-Progress
July 30, 2025
In this symposium, three experts in ATTRCM (Dr. Mathew Maurer, Dr. Sarah Cuddy, and Dr. Melissa Lyle) will explain best practices for identifying and diagnosing ATTR-CM in patients with concomitant HF, describe the evidence for current ATTR-CM therapies and, through case presentation, discuss practical considerations in management.
No Credit Available
July 29, 2025
In this symposium, attendees will be provided with best practices by a multidisciplinary faculty on the prevention of hyperkalemia, identification of patients at risk for hyperkalemia, the importance of maintaining HF patients on RAASis and preferably at target doses, recent clinical evidence with novel potassium binders, and strategies for effective communication with patients.
No Credit Available
May 20, 2025
In this symposium, experts in ICH management will discuss the clinical evidence for blood pressure control and DOAC reversal and provide illustrative case studies. Results of studies focusing on bundles of care will be summarized, and faculty members will provide insights for an adoption of this strategy to improve patient outcomes.
CME Credit Obtained Off Site
October 30, 2024
In this symposium, an expert multidisciplinary faculty will provide insights into and interpretations of clinical data, and challenging cases will reinforce key elements of prudent management of major bleeding in patients taking DOACs and experiencing intracranial hemorrhage.
No Credit Available
October 14, 2024
In this program, ATTR-PN experts (chair Dr. Morie Gertz, and faculty members Dr. Amanda Peltier and Dr. Michelle Mauermann) will present, through lectures and “realworld” case studies, current evidence and best practices for management of ATTR-PN.
No Credit Available
August 04, 2024
In this educational initiative, the current definition and clinical impact of WHF will be described, and principles of management explained.
No Credit Available
March 12, 2023
This program will focus on why clinicians must have a greater recognition of the risks and potential consequences of anticoagulant reversal in patients receiving anticoagulant therapies and the treatment algorithms for initiating reversal therapy in the diverse and expanding patient populations who use anticoagulants.
No Credit Available
March 23, 2022
In this program, HF experts will provide insights into mechanisms and clinical evidence for improving myocardial contractility, and emphasize the need for a more personalized treatment of HFrEF to optimize patient outcomes.
No Credit Available
March 19, 2022
Information on best uses of SGLT2 inhibitors for patients with HF will be disseminated through lecture, interactive case presentation, panel discussion, and question-and-answer with experts.
No Credit Available
March 13, 2022
In this program, Chair Dr. S. Claiborne Johnston, Dr. Brett Cucchiara, Dr. Louise McCullough, and Dr. Carlos Molina will interpret the evidence for DAPT, provide insights into the choice of clopidogrel or ticagrelor to add to ASA, describe deficiencies in care preventing optimal use of DAPT, and explain remedies.
No Credit Available
July 28, 2021
In this program, experts in the use of antiplatelet therapy in CAD and acute ischemic stroke/TIA will describe best uses of antiplatelet therapy to optimize clinical outcomes in these settings.
No Credit Available